Published in Brain Behav Immun on March 13, 2007
Influenza Challenge in Mood Disorders | NCT02415166
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry (2013) 4.12
From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull (2014) 2.39
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One (2011) 2.30
Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology (2010) 2.29
Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 2.12
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci (2009) 1.89
Religion, spirituality, and health: the research and clinical implications. ISRN Psychiatry (2012) 1.73
Immune suppression and immune activation in depression. Brain Behav Immun (2010) 1.48
Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 1.42
Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol (2014) 1.41
Depression and immunity: a role for T cells? Brain Behav Immun (2009) 1.40
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol Med (2010) 1.38
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol (2007) 1.36
Practitioner empathy and the duration of the common cold. Fam Med (2009) 1.33
Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun (2009) 1.31
Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol (2011) 1.26
Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci (2008) 1.25
Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: a prospective, longitudinal study. PLoS One (2011) 1.24
A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev (2009) 1.24
A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci (2012) 1.20
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler (2015) 1.18
I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res (2010) 1.16
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun (2008) 1.13
Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci U S A (2008) 1.12
Relationship between diet and mental health in children and adolescents: a systematic review. Am J Public Health (2014) 1.11
Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun (2010) 1.11
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun (2015) 1.10
Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun (2009) 1.08
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Sex differences in white matter alterations accompanying obstructive sleep apnea. Sleep (2012) 1.06
Inflammatory T helper 17 cells promote depression-like behavior in mice. Biol Psychiatry (2012) 1.05
Reconsidering the placebo response from a broad anthropological perspective. Cult Med Psychiatry (2009) 1.05
The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry (2010) 1.05
Hypothalamic mechanisms in cachexia. Physiol Behav (2010) 1.04
Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am (2011) 1.04
Immune system dysregulation in adolescent major depressive disorder. J Affect Disord (2008) 1.04
Cyclic adenosine monophosphate differentiated beta-endorphin neurons promote immune function and prevent prostate cancer growth. Proc Natl Acad Sci U S A (2008) 1.03
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun (2008) 1.03
Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety (2013) 1.02
The possible role of the kynurenine pathway in anhedonia in adolescents. J Neural Transm (Vienna) (2011) 0.99
Cognitive Behavioral Therapy and Tai Chi Reverse Cellular and Genomic Markers of Inflammation in Late-Life Insomnia: A Randomized Controlled Trial. Biol Psychiatry (2015) 0.99
Cancer-related and treatment-related fatigue. Gynecol Oncol (2014) 0.98
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
Prenatal programing: at the intersection of maternal stress and immune activation. Horm Behav (2012) 0.97
Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) (2011) 0.97
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol (2010) 0.97
Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation (2011) 0.96
Cortisol and depressive symptoms in a population-based cohort of midlife women. Psychosom Med (2010) 0.96
Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun (2011) 0.96
Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med (2010) 0.95
Religious versus Conventional Psychotherapy for Major Depression in Patients with Chronic Medical Illness: Rationale, Methods, and Preliminary Results. Depress Res Treat (2012) 0.95
Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med (2013) 0.94
Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol (2011) 0.94
Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats. Psychoneuroendocrinology (2008) 0.94
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms. Brain Behav Immun (2011) 0.93
CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice. PLoS One (2012) 0.90
Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand (2010) 0.90
Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults. Am J Geriatr Psychiatry (2012) 0.90
Interleukin-10: a key cytokine in depression? Cardiovasc Psychiatry Neurol (2009) 0.90
Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2011) 0.89
Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol (2009) 0.89
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology (2013) 0.87
Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability. PLoS One (2013) 0.87
Multisystem resiliency moderates the major depression-telomere length association: findings from the Heart and Soul Study. Brain Behav Immun (2013) 0.87
A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol (2009) 0.87
Glucocorticoids regulate natural killer cell function epigenetically. Cell Immunol (2014) 0.87
Selection of suitable housekeeping genes for real-time quantitative PCR in CD4(+) lymphocytes from asthmatics with or without depression. PLoS One (2012) 0.87
Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep (2013) 0.86
Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry (2014) 0.86
Immunomodulatory effects mediated by serotonin. J Immunol Res (2015) 0.85
Neuroimmune mechanisms of alcohol and drug addiction. Int Rev Neurobiol (2014) 0.84
Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder. Psychiatry Investig (2013) 0.84
Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitis. PLoS One (2014) 0.83
Inflammatory biomarkers and emotional approach coping in men with prostate cancer. Brain Behav Immun (2013) 0.83
The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol (2009) 0.83
Motivation and placebos: do different mechanisms occur in different contexts? Philos Trans R Soc Lond B Biol Sci (2011) 0.82
Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Anxiety Disord (2012) 0.82
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) (2014) 0.82
Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. Brain Behav Immun (2015) 0.81
Experimental human endotoxemia enhances brain activity during social cognition. Soc Cogn Affect Neurosci (2013) 0.81
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? Psychopharmacology (Berl) (2015) 0.81
Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha. Brain Behav Immun (2011) 0.80
Children with both asthma and depression are at risk for heightened inflammation. J Pediatr (2013) 0.80
Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study. J Psychosom Res (2013) 0.80
Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease. Psychosom Med (2016) 0.80
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC Psychiatry (2012) 0.80
Are children and adolescents with food allergies at increased risk for psychopathology? J Psychosom Res (2014) 0.80
Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry. Braz J Med Biol Res (2013) 0.79
Peripheral inflammatory markers in amnestic mild cognitive impairment. Int J Geriatr Psychiatry (2013) 0.79
Pairwise measures of causal direction in the epidemiology of sleep problems and depression. PLoS One (2012) 0.79
The association of mental health over time with cardiac outcomes in HEMO study patients. Clin J Am Soc Nephrol (2012) 0.79
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry (2003) 3.68
Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05
Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry (2004) 2.83
Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun (2006) 2.78
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (2013) 2.68
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 2.12
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry (2008) 1.96
Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs (2005) 1.93
Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry (2003) 1.92
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80
The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72
Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry (2008) 1.70
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol (2005) 1.63
Is depression an inflammatory disorder? Curr Psychiatry Rep (2011) 1.60
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51
Adherence to the mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation (2007) 1.51
Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology (2004) 1.51
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry (2012) 1.48
Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun (2004) 1.43
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol (2012) 1.35
Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci (2009) 1.30
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun (2008) 1.30
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord (2009) 1.28
Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry (2008) 1.27
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry (2004) 1.26
Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry (2010) 1.14
Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology (2007) 1.13
Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun (2012) 1.11
Breast cancer and depression. Oncology (Williston Park) (2004) 1.08
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells. Neuropsychopharmacology (2005) 1.01
Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med (2008) 1.01
Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings. Neuropsychobiology (2005) 1.00
Association between posttraumatic stress disorder and inflammation: a twin study. Brain Behav Immun (2013) 0.99
Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis (2008) 0.99
Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol (2011) 0.98
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav Immun (2013) 0.98
Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer (2013) 0.97
Treatment of cytokine-induced depression. Brain Behav Immun (2002) 0.94
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology (2013) 0.93
Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet (2009) 0.93
Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells. Brain Behav Immun (2009) 0.92
Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue. Brain Behav Immun (2011) 0.92
Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr Res (2004) 0.91
Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav Immun (2013) 0.89
Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin Ther Targets (2008) 0.89
Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology (2006) 0.89
Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment. Mod Trends Pharmacopsychiatri (2013) 0.86
Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study. Psychosom Med (2008) 0.86
Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull (2002) 0.86
Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics. Am J Drug Alcohol Abuse (2003) 0.86
Do cytokines really sing the blues? Cerebrum (2013) 0.84
Neonatal viral infection decreases neuronal progenitors and impairs adult neurogenesis in the hippocampus. Neurobiol Dis (2002) 0.84
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology (2012) 0.84
Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci (2011) 0.83
Cytokines, p38 MAP kinase and the pathophysiology of depression. Neuropsychopharmacology (2006) 0.83
Three independent techniques localize expression of transcript afp-11 and its bioactive peptide products to the paired AVK neurons in Ascaris suum: in situ hybridization, immunocytochemistry, and single cell mass spectrometry. ACS Chem Neurosci (2012) 0.82
Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. J Psychiatr Res (2006) 0.81
Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha. Brain Behav Immun (2011) 0.80
Collagen scaffolds in bone sialoprotein-mediated bone regeneration. ScientificWorldJournal (2013) 0.80
Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor. Bioorg Med Chem (2008) 0.80
Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia. Schizophr Bull (2002) 0.80
Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis. Neuropsychopharmacology (2002) 0.79
On redefining the role of the immune system in psychiatric disease. Biol Psychiatry (2006) 0.78
Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors. Psychooncology (2014) 0.78
Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. J Clin Psychiatry (2004) 0.78
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings. Neuropsychopharmacology (2013) 0.78
Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor. AJR Am J Roentgenol (2014) 0.77
[Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression]. J Soc Biol (2003) 0.77
Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report. Brain Behav Immun (2013) 0.77
Letter to the Editor Re: "an inflammatory review of glucocorticoids in the CNS" by Sorrells et al. Brain, Behavior and Immunity 21, 259-272, 2007. Brain Behav Immun (2007) 0.76
Interleukin-1 mediates long-term hippocampal dentate granule cell loss following postnatal viral infection. J Mol Neurosci (2009) 0.76
Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors. Am J Clin Oncol (2015) 0.76
Neurotherapeutic implications of brain-immune interactions. Neuropsychopharmacology (2014) 0.76
Thromboelastography Does Not Detect Preinjury Antiplatelet Therapy in Acute Trauma Patients. Am Surg (2016) 0.75
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. Mod Trends Pharmacopsychiatri (2017) 0.75
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies. Psychother Psychosom (2017) 0.75
Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. J Interferon Cytokine Res (2004) 0.75